Sign in to view content

An Assessment of the Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trial Patients With nAMD

Marco A. Zarbin, MD, PhD

Video
Published 2023

Related

Episode 146: Journal Club Discussing PIVOT trial, FLUID trial, Timing of Macula-Off RDs
Jayanth Sridhar, MD
Member Podcasts
2018
Intravitreal Aflibercept 8 mg in Patients With Polypoidal Choroidal Vasculopathy Phase 3 PULSAR Trial Subgroup Analysis
David T.W. Wong, MD, FRCS(C), FASRS
Annual Meeting Talks
2023
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020

Category: AMD-Neovascular

See more